Fiche centre
John Walton Muscular Dystrophy Research Centre
Newcastle upon Tyne — United Kingdom
Essais liés4clinical trials
VilleNewcastle upon Tynelocalisation
PaysUnited Kingdomlocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT05481879
Essais cliniques associés
4| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| DYNE-101 | Myopathies | Phase 1/2 | NCT05481879 | ACHIEVE — Safety, Tolerability, Pharmacodynamic, Efficacy, and Pharmacokinetic Study of DYNE-101 in Participants With Myotonic Dystrophy Type 1 | ACTIVE_NOT_RECRUITING |
| International GNE Myopathy Patient Registry | Myopathies | À vérifier | NCT04009226 | International GNE Myopathy Patient Registry | COMPLETED |
| The United Kingdom Facioscapulohumeral Muscular Dystrophy Patient Registry | Myopathies | À vérifier | NCT04001582 | The United Kingdom Facioscapulohumeral Muscular Dystrophy Patient Registry | RECRUITING |
| GRASP-01-002 — Defining Endpoints in Becker Muscular Dystrophy | Myopathies | À vérifier | NCT05257473 | GRASP-01-002 — Defining Endpoints in Becker Muscular Dystrophy | ACTIVE_NOT_RECRUITING |